SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007869
Filing Date
2022-05-09
Accepted
2022-05-09 17:00:45
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mxct-20220331x10q.htm   iXBRL 10-Q 1131333
2 EX-31.1 mxct-20220331xex31d1.htm EX-31.1 14361
3 EX-31.2 mxct-20220331xex31d2.htm EX-31.2 13579
4 EX-32.1 mxct-20220331xex32d1.htm EX-32.1 7722
5 EX-32.2 mxct-20220331xex32d2.htm EX-32.2 7095
  Complete submission text file 0001558370-22-007869.txt   4935559

Data Files

Seq Description Document Type Size
6 EX-101.SCH mxct-20220331.xsd EX-101.SCH 34173
7 EX-101.CAL mxct-20220331_cal.xml EX-101.CAL 50534
8 EX-101.DEF mxct-20220331_def.xml EX-101.DEF 125361
9 EX-101.LAB mxct-20220331_lab.xml EX-101.LAB 354053
10 EX-101.PRE mxct-20220331_pre.xml EX-101.PRE 253692
53 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20220331x10q_htm.xml XML 750713
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40674 | Film No.: 22905955
SIC: 8731 Services-Commercial Physical & Biological Research